Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrodysplasia Ossificans Progressiva”

24 trials

Showing 20 of 24 results

Not applicableLooking for participantsNCT06089616
What this trial is testing

Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ipsen 100
Large-scale testing (Phase 3)Study completedNCT03312634
What this trial is testing

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 107
Testing effectiveness (Phase 2)Ended earlyNCT02521792
What this trial is testing

In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 6
Not applicableStudy completedNCT02322255
What this trial is testing

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 114
Testing effectiveness (Phase 2)Study completedNCT02190747
What this trial is testing

An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 40
Not applicableLooking for participantsNCT06724562
What this trial is testing

IL1 Inhibition in FOP

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
University of California, San Francisco 11
Early research (Phase 1)Study completedNCT05099445
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Who this might be right for
Renal ImpairmentHemodialysis
Incyte Corporation 48
Large-scale testing (Phase 3)Study completedNCT05027802
What this trial is testing

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen 61
Not applicableStudy completedNCT02066324
What this trial is testing

Urine Sample Collection From FOP Patients

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Novartis Pharmaceuticals 25
Large-scale testing (Phase 3)WithdrawnNCT04577820
What this trial is testing

Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodyplasia Ossificans Progressiva (FOP)Heterotopic Ossification (HO)
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT05394116
What this trial is testing

Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals 63
Large-scale testing (Phase 3)Active Not RecruitingNCT06508021
What this trial is testing

Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ashibio Inc 92
Testing effectiveness (Phase 2)UnknownNCT04307953
What this trial is testing

Saracatinib Trial TO Prevent FOP

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Amsterdam UMC, location VUmc 20
Not applicableStudy completedNCT04665323
What this trial is testing

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ipsen 411
Testing effectiveness (Phase 2)Study completedNCT02279095
What this trial is testing

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 58
Large-scale testing (Phase 3)Not Yet RecruitingNCT07559513
What this trial is testing

Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT03188666
What this trial is testing

Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals 44
Not applicableLooking for participantsNCT02745158
What this trial is testing

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
The International FOP Association 800
Testing effectiveness (Phase 2)Looking for participantsNCT05090891
What this trial is testing

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Incyte Corporation 98
Early research (Phase 1)Study completedNCT04818398
What this trial is testing

Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Daiichi Sankyo Co., Ltd. 48
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation